Kodu・Aktsiate loetelu・Thermo Fisher Scientific Inc

Thermo Fisher Scientific Inc

Suletud

SektorTervishoid

573.66 -0.32

Osta Müü

Ülevaade

Aktsiahinna muutus

24h

Praegune

Min

573.61

Max

577.21

Põhinäitajad
By Trading Economics
Sissetulek	85M 1.7B
Müük	989M 12B
P/E Sektori keskmine	30.575 64.641
Aktsiakasum	6.03
Dividenditootlus	0.15
Kasumimarginaal	14.516
Töötajad	125,000
EBITDA	262M 2.6B

Soovitused
By TipRanks
Soovitused	Osta
12 kuu keskmine prognoos	+6.98% upside

Dividendid
By Acuity
Dividenditootlus Sektori keskmine	0.15% 2.31%
Järgmine tulemuste avaldamine	21. okt 2026
Järgmine dividendimakse kuupäev	15. okt 2026
Järgmine aktsia dividendi kuupäev (ex-date)	15. sept 2026

Turustatistika
By TradingEconomics
Turukapital	17B 213B
Eelmine avamishind	573.98
Eelmine sulgemishind	573.66

Uudiste sentiment

By Acuity

39%

61%

103 / 340 Pingereas Healthcare

Thermo Fisher Scientific Inc Graafik

Mineviku tootlus ei ole usaldusväärne näitaja tulevaste tulemuste kohta.

Seotud uudised

1. aug 2026, 00:01 UTC

Thermo Fisher Scientific Inc shares are trading lower in after-market hours, reflecting a decline during the session despite being above the 20-day moving average.

31. juuli 2026, 22:41 UTC

Correlated Moves

Thermo Fisher Scientific Inc. shares are lower in after-market trading, influenced by a broader market decline and rising U.S. Treasury yields amid inflation concerns.

30. juuli 2026, 19:09 UTC

Correlated Moves

Thermo Fisher Scientific Inc shares are lower amid mixed economic data, including rising jobless claims and disappointing Q2 GDP growth.

29. juuli 2026, 23:16 UTC

Thermo Fisher Scientific shares are trading roughly flat in after-market hours. The stock remains above its 20-day moving average and near its one-month range.

28. juuli 2026, 18:06 UTC

News

Social Media

Thermo Fisher Scientific shares reached a 25-week high of $588.48, reflecting strong upward momentum despite a recent pullback from earlier session highs.

27. juuli 2026, 18:01 UTC

Thermo Fisher Scientific Inc. shares are lower today amid a broader market reaction to falling oil prices, despite easing geopolitical tensions surrounding Iran.

24. juuli 2026, 19:23 UTC

News

Social Media

Thermo Fisher Scientific shares are lower today despite strong Q2 results and revenue of $11.99 billion. Barclays and Deutsche Bank raised price targets to $650 and $635, respectively.

23. juuli 2026, 23:01 UTC

Thermo Fisher Scientific shares declined in after-market trading, touching a session low before a slight recovery. The stock remains above its 20-day moving average.

22. juuli 2026, 23:02 UTC

Social Media

Thermo Fisher Scientific is set to report earnings, with analysts estimating revenue of $11.71 billion and EPS of $5.72. Shares are higher in after-market trading.

21. juuli 2026, 22:01 UTC

Thermo Fisher Scientific shares are higher in after-market hours, supported by positive market sentiment from strong earnings reports, despite recent lower finishes.

20. juuli 2026, 19:46 UTC

Shares of Thermo Fisher Scientific Inc. are lower today, reflecting routine intraday fluctuations within the asset's one-month trading range.

Võrdlus sarnastega

Hinnamuutus

Thermo Fisher Scientific Inc Prognoos

Hinnasiht

By TipRanks

6.98% tõus

12 kuu keskmine prognoos

Keskmine 614.41 USD 6.98%

Kõrge 690 USD

Madal 520 USD

Põhineb 19 Wall Streeti analüütiku instrumendi Thermo Fisher Scientific Inc 12 kuu hinnasihil - viimase 3 kuu andmed.

Hinnangu Konsensus

By TipRanks

Osta

19 ratings

Osta

Hoia

Müü

Põhineb 19 analüütiku instrumendi Thermo Fisher Scientific Inc aktsia reitingul - viimase 3 kuu andmed.

Sentiment

By Acuity

103 / 340 Pingereas Tervishoid

Finantsandmed

Müügi- ja halduskulud

Tegevuskulud

Maksueelne kasum

Müük

Müügikulu

Brutokasum müügist

Intressikulud võla pealt

EBITDA

Ärikasum

Ettevõttest Thermo Fisher Scientific Inc

Thermo Fisher Scientific Inc. provides life sciences solutions, analytical instruments, specialty diagnostics, and laboratory products and biopharma services in the North America, Europe, Asia-Pacific, and internationally. The company's Life Sciences Solutions segment offers reagents, instruments, and consumables for biological and medical research, discovery, and production of drugs and vaccines, as well as diagnosis of infections and diseases; and solutions include biosciences, genetic sciences, and bio production to pharmaceutical, biotechnology, agricultural, clinical, healthcare, academic, and government markets. Its Analytical Instruments segment provides instruments, consumables, software, and services for pharmaceutical, biotechnology, academic, government, environmental, and other research and industrial markets, as well as clinical laboratories. The company's Specialty Diagnostics segment offers liquid, ready-to-use, and lyophilized immunodiagnostic reagent kits, as well as calibrators, controls, protein detection assays, and instruments; immunodiagnostics develops, manufactures and markets complete bloodtest systems to support the clinical diagnosis and monitoring of allergy, asthma and autoimmune diseases; dehydrated and prepared culture media, collection and transport systems, instrumentation, and consumables; human leukocyte antigen typing and testing for organ transplant market; and healthcare products. Its Laboratory Products and Biopharma Services segment provides laboratory products, research and safety market channel, and pharma services and clinical research. It offers products and services through a direct sales force, customer-service professionals, electronic commerce, and third-party distributors under Thermo Scientific; Applied Biosystems; Invitrogen; Fisher Scientific; Unity Lab Services; and Patheon and PPD. It has a collaboration agreement with Mainz Biomed N.V. for the development of colorectal cancer screening product. Thermo Fisher Scientific Inc. was founded in 1956 and is headquar